Page 17 - Flipbook
P. 17
PATRON
Primary Outcome Measures:
failure-free survival (FFS)
Secondary Outcome Measures:
Rates of toxicity (CTCAE)
Time to subsequent next-line therapy
Quality of Life (EPIC 26)
New lesion detection yield (on PSMA PET/CT)
Impact of PMSA PET/CT on RT or surgical management (rate of
treatment intensification)
Cost-effectiveness (EQ5D5L)
